|
WO2011080401A1
|
|
Receptor tyrosine kinase-binding compositions
|
|
CA2738034A1
|
|
Materials and methods for inhibiting cancer cell invasion related to fgfr4
|
|
US2008241168A1
|
|
Transmembrane protein amigo and uses thereof
|
|
WO2008096046A1
|
|
Noroxymorphone for use as a medicament
|
|
WO2008062105A1
|
|
Method for predicting the response to a therapy
|
|
US2008241818A1
|
|
Method and microarray for detecting herpesviruses
|
|
US2009214496A1
|
|
Bmx/etk tyrosine kinase gene therapy materials and methods
|
|
EP1977010A1
|
|
Method of identifying lung cancers associated with asbestos-exposure
|
|
US2007082848A1
|
|
VEGF-C or VEGF-D materials and methods for treatment of neuropathologies
|
|
US2008103088A1
|
|
Alternative oxidase and uses thereof
|
|
US2006195915A1
|
|
Novel neurotrophic factor protein and uses thereof
|
|
CA2633468A1
|
|
Novel neurotrophic factor protein and uses thereof
|
|
WO2006002854A2
|
|
Tie receptor and tie ligand materials and methods for modulating female fertility
|
|
US2006085149A1
|
|
Method and apparatus for computation of electrostatic potential
|
|
US2006025338A1
|
|
Compositions and methods for treatment of lymphatic and venous vessel arterialization
|
|
US2006258576A1
|
|
Gdnf-related neuropeptides
|
|
US2007026405A1
|
|
Materials and methods for colorectal cancer screening, diagnosis and therapy
|
|
AU2004201020A1
|
|
Use of VEGF-C or VEGF-D Gene or Protein to Prevent Restenosis
|
|
WO2004078775A2
|
|
Intracellular signaling-induced ret-independent gdnf receptor-effected morphological changes
|
|
WO2004055055A1
|
|
The transmembrane protein amigo and uses thereof
|
